These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8752444)

  • 21. Early treatment.
    Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple sclerosis: diagnostic procedures and current therapeutic developments].
    Kappos L
    Schweiz Med Wochenschr; 1995 Jun; 125(25):1251-63. PubMed ID: 7610362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
    Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
    Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from randomised direct comparative trials.
    Achiron A; Fredrikson S
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
    Sormani MP; Bonzano L; Roccatagliata L; De Stefano N
    Mult Scler; 2011 May; 17(5):630-3. PubMed ID: 21177320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis. II. A critical assessment of immunotherapy.
    Durelli L; Bergamini L
    Riv Neurol; 1989; 59(5):191-201. PubMed ID: 2483962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Magnetic resonance imaging after a one-month interval of lesions of multiple sclerosis in 2 populations, one during an acute attack treated with methylprednisolone, the other stable with no treatment].
    Rumbach L; Dietemann JL; Tranchant C; Bodiguel E; Warter JM; Collard M
    Rev Neurol (Paris); 1990; 146(6-7):430-3. PubMed ID: 2399406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging in the diagnosis and follow-up of patients with multiple sclerosis.
    Paty DW
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):125-31. PubMed ID: 1345733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple sclerosis].
    Nyland H; Myhr KM
    Tidsskr Nor Laegeforen; 1995 Jun; 115(17):2072-7. PubMed ID: 7544032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging in multiple sclerosis.
    Miller DH; McDonald WI
    Clin Neurosci; 1994; 2(3-4):215-24. PubMed ID: 7749891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific treatment of multiple sclerosis.
    Silberberg DH
    Clin Neurosci; 1994; 2(3-4):271-4. PubMed ID: 7749898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapeutics of multiple sclerosis.
    Durelli L
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peculiar difficulties of therapeutic trials for multiple sclerosis.
    Myers LW; Ellison GW
    Neurol Clin; 1990 Feb; 8(1):119-41. PubMed ID: 1690838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy in multiple sclerosis, Part 2.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history and treatment of multiple sclerosis.
    Weinshenker BG; Sibley WA
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):203-11. PubMed ID: 1377973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.